Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$225.07 - $246.17 $3.82 Million - $4.18 Million
16,970 Added 4.22%
419,320 $98 Million
Q1 2024

May 02, 2024

BUY
$233.45 - $247.73 $4.39 Million - $4.65 Million
18,786 Added 4.9%
402,350 $99.6 Million
Q4 2023

Feb 01, 2024

BUY
$232.24 - $267.23 $763,372 - $878,385
3,287 Added 0.86%
383,564 $93.5 Million
Q3 2023

Oct 31, 2023

BUY
$254.9 - $283.59 $31.4 Million - $35 Million
123,347 Added 48.01%
380,277 $98.3 Million
Q2 2023

Aug 03, 2023

BUY
$238.39 - $265.32 $61.2 Million - $68.2 Million
256,930 New
256,930 $67.8 Million
Q2 2021

Aug 12, 2021

SELL
$232.65 - $254.58 $63.7 Million - $69.7 Million
-273,742 Closed
0 $0
Q1 2021

May 11, 2021

BUY
$232.09 - $256.88 $22.5 Million - $24.9 Million
97,014 Added 54.89%
273,742 $66.6 Million
Q4 2020

Feb 05, 2021

BUY
$221.92 - $245.94 $39.2 Million - $43.5 Million
176,728 New
176,728 $44.2 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.